Active chemical ingredients for use in the manufacture of pharmaceuticals; agglutinants for use in the manufacture of pharmaceuticals; alcohol for use in manufacturing pharmaceuticals; antioxidants for use in the manufacture of pharmaceuticals; cellulose esters for use in the manufacture of pharmaceuticals; cellulose ethers for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; chemically activated adhesive label for sensing the presence of oxygen in intravenous medical and pharmaceutical containers; chlorine for use in the manufacture of pharmaceuticals; emollients for use in the manufacture of pharmaceuticals; emulsifiers for the manufacture of pharmaceuticals; glycolic extracts for use in the manufacture of pharmaceuticals; phenothiazine for use as a pharmaceutical intermediate; phenothiazine for use in the manufacture of pharmaceuticals; plant extracts for use in the manufacture of pharmaceuticals; preservatives for pharmaceutical preparations; reagents for testing the sterility of pharmaceuticals and injectable solutions; siccatives for use in the manufacture of pharmaceuticals; tea extracts for use in the manufacture of pharmaceuticals

Aluminium acetate for pharmaceutical purposes; anti-diabetic pharmaceuticals; anti-epileptic pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; antidiabetic pharmaceuticals; antiepileptic pharmaceutical preparations; antifungal pharmaceutical preparations; antiviral pharmaceutical preparations; bismuth preparations for pharmaceutical purposes; bismuth preparations for pharmaceutical use; bismuth subnitrate for pharmaceutical purposes; bromine for pharmaceutical purposes; cardiovascular pharmaceuticals; collodion for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; ergot for pharmaceutical purposes; ethanol for pharmaceutical purposes; ethyl alcohol for pharmaceutical purposes; eucalyptol for pharmaceutical purposes; eucalyptus for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; frostbite salve for pharmaceutical purposes; gallic acid for pharmaceutical purposes; garlic for pharmaceutical purposes; gentian for pharmaceutical purposes; guaiacol for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; injectable pharmaceutical contraceptives; injectable pharmaceuticals for treatment of anaphylactic reactions; lactose for pharmaceutical purposes; linseed for pharmaceutical purposes; liquorice for pharmaceutical purposes; lupulin for pharmaceutical purposes; menthol for pharmaceutical purposes; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; pharmaceutical antibody preparations for respiratory disease; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical antitussive-cold preparations; pharmaceutical astringents; pharmaceutical cold preparations; pharmaceutical grade lactose; pharmaceutical preparations and substances for the prevention of diabetes; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for inducing erections; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in humans; pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in humans; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of chronic liver diseases; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections.; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of duchenne muscular dystrophy; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of eye infections; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of mastitis; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of multiple sclerosis, namely, topical creams containing cannabidiol; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic conditions; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of presbyopia; pharmaceutical preparations for the treatment of primary hyperoxaluria; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of renal diseases, cardiovascular diseases, liver diseases, pulmonary diseases, metabolic diseases, cancer, hematology, central nervous system diseases, diabetes, vascular diseases and fibrosis; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of rosacea; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of tuberculosis; pharmaceutical preparations for the treatment of urovaginal infections; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of worms in pets; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating and preventing skin and nail diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating digestive system disorders; pharmaceutical preparations for treating dry skin caused by pregnancy; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating high cholesterol; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment of coronavirus; pharmaceutical preparations for treatment of coronavirus infection; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical solutions used in dialysis; pharmaceuticals for ophthalmological use; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of coronavirus diseases and COVID-19; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals for treating respiratory diseases; pharmaceuticals for treating the symptoms of radiation sickness; phenol for pharmaceutical purposes; polygonatum sibiricum for pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pre-filled syringes with pharmaceutical preparations for treating auto-immune diseases; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; rhubarb roots for pharmaceutical purposes; royal jelly for pharmaceutical purposes; starch for pharmaceutical purposes; stick liquorice for pharmaceutical purposes; sunburn preparations for pharmaceutical purposes; synthetic peptides for pharmaceutical purposes; tartar for pharmaceutical purposes; thymol for pharmaceutical purposes; topical pharmaceutical creams for the treatment of dermatitis, eczema and psoriasis; transdermal pharmaceutical patches impregnated with insect repellent; turpentine for pharmaceutical purposes; unit dose capsules sold empty for pharmaceutical use; unit dose capsules, empty, for pharmaceutical purposes